Parathyroid Hormone Analog Market By Product Type ( Abaloparatide, Teriparatide, Human Parathyroid Hormone Recombinant ), By Application ( Hospitals, Clinics ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 164

 ERC 6229

Parathyroid Hormone Analog Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Parathyroid hormone, also called as (PTH) analogue is a synthetic form of naturally occurring parathyroid hormone, which is used as a medication therapy in order to increase bone strength, propelling the formation of bone mass. Parathyroid hormone analogs extensively control the proper distribution of elements such as phosphate and calcium in the human body. People having reduced amount of parathyroid hormone can severely suffer reduced amount of calcium in the bones, which might generate diseases such as Osteoprosis. Osteoprosis is a condition when the bones become fragile and get brittle in nature. Recombinant human parathyroid hormone (PTH) analogues and teriparatides are the most adopted medication therapies for this medical condition as these analogs increase the possibility of increasing the formation of new bone substance because of anabolic effects presented by them. PTH analogs not only provides bone strength but also improves the microarchitecture of the complete skeleton. However, the need for daily self-injection and the extremely high cost of the treatment might act as a major restraining factor for the very market. As per the statistics revealed by the International Osteoporosis foundation, Osteoporosis causes more than 8.9 million fractures annually, all over the world, resulting in an osteoporotic fracture every 3 seconds. By 2050, the worldwide incidence of hip fracture in men is estimated to escalate by 310% and 240% in women, compared to rates in 1990. This clearly depicts that the market is yet to experience a bright growth in the upcoming future.

The report provides detailed qualitative and quantitative analysis of the Parathyroid Hormone Analog Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Parathyroid Hormone Analog Market Player Analysis -

The report presents detailed analysis of major players operating in Parathyroid Hormone Analog Market. Few of the include Pfizer, Abbott Laboratories, Merck, Natpara, GlaxosmithklinePlc, Sanofi Sa, Eli Lilly, Cell GenesysInc, Osi Pharmaceuticals, Paladin Labs Inc. and Alza Corporation. A detailed coverage on these market players with information on their revenue from parathyroid hormone analog business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Parathyroid Hormone Analog market is segmented on the basis of type, application and geography. By product type, the market is segmented into Abaloparatide, Teriparqatide and human parathyroid hormone recombinant. On the basis of application, the market is categorized as Hospitals, Clinics and Others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Parathyroid Hormone Analog Market Segmentation

By Product Type
   • Abaloparatide
   • Teriparatide
   • Human Parathyroid Hormone Recombinant

By Application
   • Hospitals
   • Clinics
   • Other

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K.
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Parathyroid Hormone Analog Market Key Players

• Pfizer
• Abbott Laboratories
• Merck
• Natpara
• Glaxosmithkline Plc
• Sanofi Sa
• Eli Lilly
• Cell Genesys Inc
• Osi Pharmaceuticals
• Paladin Labs Inc.
• Alza Corporation

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Parathyroid Hormone Analog Market in 2017 and the expected market size by 2022, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2022)?
    • Which are the leading companies in the Parathyroid Hormone Analog Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?


Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com